Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited-Stage Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05502523
What this trial is testing

The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+1 more
Thomas Jefferson University 100
Testing effectiveness (Phase 2)WithdrawnNCT00104754
What this trial is testing

Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Not applicableUnknownNCT01337037
What this trial is testing

Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
Peking University People's Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT00567359
What this trial is testing

Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR

Who this might be right for
Non-small Cell Lung Cancer
Massachusetts General Hospital 100
Not applicableLooking for participantsNCT06467383
What this trial is testing

Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

Who this might be right for
Non-small Cell Lung CancerNSCLCNSCLC, Stage III+1 more
MSD Italia S.r.l. 600
Not applicableStudy completedNCT01209520
What this trial is testing

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

Who this might be right for
Lung CancerNon Small Cell Lung CarcinomaHypermethylation
University of Miami 6
Not applicableEnded earlyNCT03553550
What this trial is testing

Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation

Who this might be right for
Non Small Cell Lung Cancer
Addario Lung Cancer Medical Institute 38
Testing effectiveness (Phase 2)Study completedNCT04735068
What this trial is testing

Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerKRAS Mutation-Related Tumors
Abramson Cancer Center at Penn Medicine 9
Not applicableLooking for participantsNCT04790253
What this trial is testing

PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)

Who this might be right for
Limited Stage Small Cell Lung CancerExtensive-stage Small-cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 600
Very early researchStudy completedNCT02357836
What this trial is testing

Neoadjuvant Itraconazole in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 13
Not applicableLooking for participantsNCT06743581
What this trial is testing

Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy
Centre hospitalier de l'Université de Montréal (CHUM) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05903092
What this trial is testing

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerSCLCExtensive Stage Small Cell Lung Cancer+1 more
Hirva Mamdani 84
Early research (Phase 1)Looking for participantsNCT03546829
What this trial is testing

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 10
Large-scale testing (Phase 3)Looking for participantsNCT07473128
What this trial is testing

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Pharmacosmos A/S 120
Early research (Phase 1)Active Not RecruitingNCT05353439
What this trial is testing

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaPlatinum-Resistant Lung Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT06477055
What this trial is testing

The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 43
Post-approval studies (Phase 4)Ended earlyNCT05583188
What this trial is testing

Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

Who this might be right for
NSCLC
Galvanize Therapeutics, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT00276796
What this trial is testing

Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 66
Testing effectiveness (Phase 2)Study completedNCT00066313
What this trial is testing

ZD6474 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Genzyme, a Sanofi Company
Not applicableStudy completedNCT00433407
What this trial is testing

T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors

Who this might be right for
Breast CancerLung CancerOvarian Cancer+3 more
Jonsson Comprehensive Cancer Center 12
Next Page